BCR and prostate cancer: After median follow up of 60 months, in single positive lymph node patients, 3 patients died due to prostate cancer, 6 patients had clinical progression of metastasis, and 20 patients had BCR and 16 patients remained with no recurrence (biochemical and clinical).